FORA Capital LLC raised its position in Envista Holdings Co. (NYSE:NVST – Free Report) by 11.1% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 52,198 shares of the company’s stock after buying an additional 5,205 shares during the quarter. FORA Capital LLC’s holdings in Envista were worth $1,116,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in NVST. Vanguard Group Inc. grew its holdings in shares of Envista by 5.8% during the 4th quarter. Vanguard Group Inc. now owns 17,167,767 shares of the company’s stock worth $413,056,000 after purchasing an additional 944,596 shares in the last quarter. Franklin Resources Inc. boosted its stake in Envista by 65.3% in the fourth quarter. Franklin Resources Inc. now owns 5,262,092 shares of the company’s stock valued at $126,606,000 after buying an additional 2,077,786 shares in the last quarter. Nuance Investments LLC boosted its stake in Envista by 953.8% in the fourth quarter. Nuance Investments LLC now owns 3,931,054 shares of the company’s stock valued at $94,581,000 after buying an additional 3,558,031 shares in the last quarter. River Road Asset Management LLC acquired a new stake in Envista in the fourth quarter valued at about $54,931,000. Finally, Charles Schwab Investment Management Inc. boosted its stake in Envista by 9.8% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,126,535 shares of the company’s stock valued at $51,164,000 after buying an additional 190,572 shares in the last quarter.
Envista Price Performance
NYSE:NVST remained flat at $16.41 during mid-day trading on Monday. The company’s stock had a trading volume of 2,555,929 shares, compared to its average volume of 2,356,251. The company has a 50 day moving average of $18.09 and a two-hundred day moving average of $20.79. Envista Holdings Co. has a twelve month low of $15.92 and a twelve month high of $36.14. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.93 and a current ratio of 2.27. The company has a market cap of $2.82 billion, a price-to-earnings ratio of -22.57, a price-to-earnings-growth ratio of 13.63 and a beta of 1.31.
Analyst Upgrades and Downgrades
Several analysts recently weighed in on NVST shares. Evercore ISI reduced their price objective on Envista from $24.00 to $19.00 and set an “outperform” rating on the stock in a research note on Tuesday, June 25th. Morgan Stanley downgraded Envista from an “overweight” rating to an “equal weight” rating and lowered their target price for the stock from $33.00 to $21.00 in a report on Friday, April 26th. The Goldman Sachs Group reduced their price objective on Envista from $20.00 to $17.50 and set a “sell” rating for the company in a research note on Friday, May 3rd. Needham & Company LLC reaffirmed a “hold” rating on shares of Envista in a research report on Monday, June 3rd. Finally, Robert W. Baird cut their target price on Envista from $22.00 to $19.00 and set a “neutral” rating on the stock in a research report on Thursday, May 2nd. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $24.86.
Read Our Latest Stock Analysis on Envista
Envista Company Profile
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Further Reading
- Five stocks we like better than Envista
- What is a Bond Market Holiday? How to Invest and Trade
- Don’t Miss These Stock Picks for the Lumber Price Surge
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- NVIDIA Stock Defies Skeptics, Earns Analyst Upgrade
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- 3 Highly Profitable Companies Set for Double-Digit Upside
Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Co. (NYSE:NVST – Free Report).
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.